Literature DB >> 33834278

Reply to the Letter to the Editor of V. Kumar et al. concerning "Primary cervical decompression surgery may improve lumbar symptoms in patients with tandem spinal stenosis" by Inoue T, et al. (Eur Spine J; 2021 Jan 6. doi: 10.1007/s00586-020-06693-0).

Taro Inoue1, Shiro Imagama2.   

Abstract

Entities:  

Year:  2021        PMID： 33834278     DOI： 10.1007/s00586-021-06803-6

Source DB:  PubMed          Journal:  Eur Spine J        ISSN： 0940-6719            Impact factor:   3.134


× No keyword cloud information.
  4 in total

1.  Prioritized cervical or lumbar surgery for coexisting cervical and lumbar stenosis: Prognostic analysis of 222 case.

Authors:  Haoxi Li; Zhaoxiong Chen; Xinhua Li; Tao Liu; Bin Shen; Yufeng Huang; Desheng Wu
Journal:  Int J Surg       Date:  2017-07-12       Impact factor: 6.071

2.  Staged surgery for tandem cervical and lumbar spinal stenosis: Which should be treated first?

Authors:  Chi-An Luo; Arun-Kumar Kaliya-Perumal; Meng-Ling Lu; Lih-Huei Chen; Wen-Jer Chen; Chi-Chien Niu
Journal:  Eur Spine J       Date:  2018-10-17       Impact factor: 3.134

3.  Postoperative Changes in Moderate to Severe Nonspecific Low Back Pain After Cervical Myelopathy Surgery.

Authors:  Chi Heon Kim; Chun Kee Chung; Urim Lee; Yunhee Choi; Sung Bae Park; Jong-Myung Jung; Sung Hwan Hwang; Seung Heon Yang
Journal:  World Neurosurg       Date:  2018-05-09       Impact factor: 2.104

4.  Coexisting cervical and lumbar spinal stenosis: diagnosis and management.

Authors:  N E Epstein; J A Epstein; R Carras; V S Murthy; R A Hyman
Journal:  Neurosurgery       Date:  1984-10       Impact factor: 4.654
  4 in total
  1 in total

1.  Letter to the editor concerning "primary cervical decompression surgery may improve lumbar symptoms in patients with tandem spinal stenosis" by Inoue T, et al. (Eur Spine J; 2021 jan 6. doi: 10.1007/s00586-020-06,693-0).

Authors:  Vishal Kumar; Sarvdeep Singh Dhatt; Sabarathinam Ravi Subramaniyam; Deepak Neradi
Journal:  Eur Spine J       Date:  2021-04-13       Impact factor: 3.134
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.